» Articles » PMID: 19048368

MCP-1-induced Migration of NT2 Neuroprogenitor Cells Involving APP Signaling

Overview
Publisher Springer
Date 2008 Dec 3
PMID 19048368
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Neuroprogenitor cells are an important resource because of their great potential to replace damaged cells in the brain caused by trauma and disease. Studies have shown that when neuroprogenitor cells are transplanted into the brain they migrate towards damaged areas, suggesting that these areas express factors that recruit migrating cells. Generally, after neuronal injury, there is a neuroinflammatory response that results in increased chemokine production. In this present study, we demonstrate that monocyte chemoattractant protein-1 (MCP-1) significantly induces the migration of NT2 neuroprogenitor cells. Activation of intracellular cyclic adenosine monophosphate or protein kinase C with forskolin and phorbol 12-myristate 13-acetate, respectively, was able to completely abolish the MCP-1-induced migration. Contrarily, neither extracellular signal-regulated kinase nor p38 mitogen-activated protein kinase was required for NT2 cells to respond to MCP-1. Previously, we showed that amyloid precursor protein (APP) activity increases MCP-1 expression in NT2 cells. We now demonstrate that NT2 cells expressing APP can induce migration of other neuroprogenitor cells. Utilizing a MCP-1 neutralizing antibody, we discovered that APP-induced migration was not caused solely by increased MCP-1 production. Interestingly, APP-increased expression of several C-C chemokines: MCP-1, regulated upon activation, normal T-cell expressed, and secreted (RANTES), and macrophage inflammatory protein alpha (MIP-1 alpha). This demonstrates the unique role APP has in regulating chemokine production, which directly affects cell migration. Taken together, these data provides greater detail of the chemotactic factors and intracellular signaling that direct neuroprogenitor cell migration, allowing for better understanding of cell migration during transplantation.

Citing Articles

From Blood to Lesioned Brain: An In Vitro Study on Migration Mechanisms of Human Nasal Olfactory Stem Cells.

Girard S, Virard I, Lacassagne E, Paumier J, Lahlou H, Jabes F Stem Cells Int. 2017; 2017:1478606.

PMID: 28698717 PMC: 5494110. DOI: 10.1155/2017/1478606.


Altered subcellular distribution of the 75-kDa DISC1 isoform, cAMP accumulation, and decreased neuronal migration in schizophrenia and bipolar disorder: implications for neurodevelopment.

Munoz-Estrada J, Benitez-King G, Berlanga C, Meza I CNS Neurosci Ther. 2015; 21(5):446-53.

PMID: 25620115 PMC: 6495214. DOI: 10.1111/cns.12377.


The effects of histone deacetylase inhibitors on glioblastoma-derived stem cells.

Alvarez A, Field M, Bushnev S, Longo M, Sugaya K J Mol Neurosci. 2014; 55(1):7-20.

PMID: 24874578 DOI: 10.1007/s12031-014-0329-0.


Autism as early neurodevelopmental disorder: evidence for an sAPPα-mediated anabolic pathway.

Lahiri D, Sokol D, Erickson C, Ray B, Ho C, Maloney B Front Cell Neurosci. 2013; 7:94.

PMID: 23801940 PMC: 3689023. DOI: 10.3389/fncel.2013.00094.


Stem cells for the treatment of neurodegenerative diseases.

Dantuma E, Merchant S, Sugaya K Stem Cell Res Ther. 2010; 1(5):37.

PMID: 21144012 PMC: 3025439. DOI: 10.1186/scrt37.

References
1.
Zimmermann G, Taussig R . Protein kinase C alters the responsiveness of adenylyl cyclases to G protein alpha and betagamma subunits. J Biol Chem. 1996; 271(43):27161-6. DOI: 10.1074/jbc.271.43.27161. View

2.
Murakami N, Yamaki T, Iwamoto Y, Sakakibara T, Kobori N, Fushiki S . Experimental brain injury induces expression of amyloid precursor protein, which may be related to neuronal loss in the hippocampus. J Neurotrauma. 1998; 15(11):993-1003. DOI: 10.1089/neu.1998.15.993. View

3.
Pleasure S, Lee V . NTera 2 cells: a human cell line which displays characteristics expected of a human committed neuronal progenitor cell. J Neurosci Res. 1993; 35(6):585-602. DOI: 10.1002/jnr.490350603. View

4.
Trojanowski J, Kleppner S, Hartley R, Miyazono M, Fraser N, Kesari S . Transfectable and transplantable postmitotic human neurons: a potential "platform" for gene therapy of nervous system diseases. Exp Neurol. 1997; 144(1):92-7. DOI: 10.1006/exnr.1996.6393. View

5.
Glabinski A, Balasingam V, Tani M, Kunkel S, Strieter R, Yong V . Chemokine monocyte chemoattractant protein-1 is expressed by astrocytes after mechanical injury to the brain. J Immunol. 1996; 156(11):4363-8. View